Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses
- 8 June 2017
- journal article
- Published by Taylor & Francis in Future Virology
- Vol. 12 (6) , 283-297
Abstract
Adeno-associated viruses (AAVs) are promising therapeutic viral vectors. Their capsid is assembled from viral proteins VP1, VP2 and VP3, aided by an assembly-activating protein, followed by replica...Keywords
This publication has 83 references indexed in Scilit:
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV VectorMolecular Therapy, 2012
- Structure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)Virology, 2011
- Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary VectorsHuman Gene Therapy, 2011
- Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6Molecular Therapy, 2011
- The structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasionVirology, 2010
- A viral assembly factor promotes AAV2 capsid formation in the nucleolusProceedings of the National Academy of Sciences, 2010
- Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated VirusMolecular Therapy, 2010
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune ResponsesMolecular Therapy, 2009
- Adeno-associated virus interactions with B23/Nucleophosmin: Identification of sub-nucleolar virion regionsVirology, 2007